Canada markets close in 3 hours 25 minutes

Acrivon Therapeutics, Inc. (ACRV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.20+0.06 (+0.74%)
As of 12:30PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
46,024
46,024
23,949
13,718
1,870
Selling General and Administrative
21,079
21,079
8,708
2,466
1,298
Total Operating Expenses
67,103
67,103
32,657
16,184
3,168
Operating Income or Loss
-67,103
-67,103
-32,657
-16,184
-3,168
Total Other Income/Expenses Net
6,715
6,715
1,490
-59
-2,138
Income Before Tax
-60,388
-60,388
-31,167
-16,243
-5,306
Income from Continuing Operations
-60,388
-60,388
-31,167
-16,243
-5,306
Net Income
-60,388
-60,388
-31,167
-16,243
-5,306
Net Income available to common shareholders
-60,388
-60,388
-31,167
-16,243
-5,306
Basic EPS
-2.26
-
-7.56
-1.26
-0.41
Diluted EPS
-2.26
-
-7.56
-1.26
-0.41
Basic Average Shares
22,104
-
4,122
12,910
12,884
Diluted Average Shares
22,104
-
4,122
12,910
12,884